Radon balneotherapy in rheumatologic diseases: potential mechanisms and implications for cardiovascular autonomic control and inflammation - Top-Institutions - MDSpire

Radon balneotherapy in rheumatologic diseases: potential mechanisms and implications for cardiovascular autonomic control and inflammation

  • By

  • Gabriel D. Rodrigues

  • Earric Lee

  • Benoit Dugué

  • Christian Hanshans

  • Maria Chiara Maccarone

  • Konstantinos Triantafyllias

  • Arnulf Hartl

  • Eugenijus Kaniusas

  • Sabrina Mörkl

  • Thomas E. Schmid

  • Goda-Camille Mickeviciute

  • Hannes Untner

  • Werner Klingler

  • Martin Offenbächer

  • June 24, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Gastein Research Institute, Paracelsus Medical University
    Gastein Research Institute, Paracelsus Medical University

    Salzburg, Austria

    Key Differentiators

    • Rheumatology
    • Balneotherapy

  • #2

    FBK Spa Medicine Research Institute
    FBK Spa Medicine Research Institute

    Bad Elster, Germany

    Key Differentiators

    • Rheumatology
    • Balneotherapy

Original Source(s)

Radon balneotherapy in rheumatologic diseases: potential mechanisms and implications for cardiovascular autonomic control and inflammation

  • by Gabriel D. Rodrigues, Earric Lee, Benoit Dugué, Christian Hanshans, Maria Chiara Maccarone, Konstantinos Triantafyllias, Arnulf Hartl, Eugenijus Kaniusas, Sabrina Mörkl, Thomas E. Schmid, Goda-Camille Mickeviciute, Hannes Untner, Werner Klingler, Martin Offenbächer

  • June 24, 2026

Related Content

RA Outcomes Improved in KURAMA Cohort

Ten-year observational data showed lower disease activity and functional disability coinciding with broader use of biologic and targeted synthetic therapies.

IL-34-mediated fibroblast-like synoviocyte-macrophage crosstalk drives bone erosion in rheumatoid arthritis through RANKL-dependent osteoclastogenesis

JAK Monotherapy Shows Efficacy in RA Review

A systematic review found Janus kinase inhibitor monotherapy improved outcomes vs methotrexate or placebo, but direct comparisons with combination therapy were limited.